North America

Frequency Therapeutics scores $42 mln Series B

Woburn, Massachusetts-based Frequency Therapeutics, a clinical-stage biotechnology company, has raised $42 million in Series B financing. Taiwania Capital Management and Axil Capital led the round with participation from Yonjin Capital, DF Investments, Polaris Founders Capital, Alexandria Venture Investments, CoBro Ventures, Korea Investment Partners and Emigrant Capital.

Atlantic Therapeutics snags Series B funding

Atlantic Therapeutics, a medical technology company focused on treating bladder leaks, has secured 28 million euros in Series B funding. LSP led the round with participation from other investors that included Andera Partners, Atlantic Bridge Ventures, Seroba Life Sciences and Earlybird Venture Capital.

CVCA appoints Amgen's Kim Furlong as new chief executive

The Canadian Venture Capital and Private Equity Association (CVCA) has appointed Kim Furlong as its new CEO. Furlong joins CVCA from Toronto-based biotechnology company Amgen Canada, where for more than a decade she served as director of federal government affairs. Before then, she was vice president, federal government relations, at the Retail Council of Canada. Furlong replaces Mike Woollatt, who served as CVCA CEO between 2014 and 2018. Last September, Woollatt left the organization to become director of strategic partnerships at OMERS Platform Investments. Founded in 1974, Toronto-based CVCA is the professional association for Canada's venture capital and private equity industry.

Aerospace startup Boom Supersonic gathers $100 mln Series B

Denver-based Boom Supersonic, an aerospace startup, has raised $100 million in Series B funding. The investors included Sunstone Management and Y Combinator Continuity.

Tusk Ventures to raise $70 mln second venture-capital fund

Tusk Ventures has set out to raise a $70 million second venture-capital fund, according to a filing with the SEC.

Ontario Teachers’ joins $1 bln financing of Alphabet's Verily

Verily Life Sciences, a life sciences research and engineering organization held by Alphabet Inc, the parent company of Google, has raised US$1 billion in financing. The round was led by U.S. technology private equity firm Silver Lake Partners. It was joined by other new investors, including Ontario Teachers’ Pension Plan. South San Francisco-based Verily develops tools and platforms that collect and organize health data to help improve healthcare delivery and clinical outcomes. The company will use the funds raised to support growth in key areas, including investments in strategic partnerships, global business development opportunities, and potential acquisitions.

Third Kind Venture Capital targets $65 mln for sophomore fund

Third Kind Venture Capital is seeking to raise $65 million for its second fund, according to an SEC filing. The New York-based venture firm is focused on early-stage investments.

Qualcomm Ventures backs Baicells

Plano, Texas-based Baicells, a small cell technology company, has secured an undisclosed amount of funding. The investor was Qualcomm Ventures LLC.

Medication guidance company WithMe Health rakes in $20 mln

Boston-based WithMe Health, a medication guidance company, has raised $20 million in financing. The investor was Oak HC/FT.

Pear Therapeutics locks in $64 mln Series C

Boston and San Francisco-based Pear Therapeutics, a provider of prescription digital therapeutics, has secured $64 million in Series C financing. Temasek led the round with participation from other investors that included Novartis, 5AM Ventures, Arboretum Ventures, Jazz Venture Partners, The Bridge Builders Collaborative, EDBI, Blue Water Life Science Fund LP and Trustbridge Partners.